Sequent Scientific Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Rajaram Narayanan

Chief Executive Officer (CEO)

₹31.2m

Compensación total

Porcentaje del salario del CEO	100.0%
Permanencia del CEO	2.6yrs
Participación del CEO	n/a
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	4yrs

Actualizaciones recientes de la dirección

Recent updates

We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt

Sep 27

What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You

Sep 05

Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?

Jan 05

What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?

Dec 24

Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?

Dec 12

Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly

Nov 22

Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)

Nov 10

The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It

Oct 20

How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?

Oct 05

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Rajaram Narayanan en comparación con los beneficios de Sequent Scientific?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	₹165m
Jun 30 2024	n/a	n/a	₹55m
Mar 31 2024	₹31m	₹31m	-₹359m
Dec 31 2023	n/a	n/a	-₹1b
Sep 30 2023	n/a	n/a	-₹1b
Jun 30 2023	n/a	n/a	-₹1b
Mar 31 2023	₹49m	₹49m	-₹1b

Compensación vs. Mercado: La compensación total de Rajaram($USD368.70K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD257.40K).

Compensación vs. Ingresos: La compensación de Rajaram ha sido consistente con los resultados de la empresa en el último año.

CEO

Rajaram Narayanan (56 yo)

2.6yrs

Permanencia

₹31,180,000

Compensación

Mr. Rajaram Narayanan serves as Managing Director & Chief Executive Officer at Sequent Scientific Limited since April 11, 2022 and also serves as its Director since April 11, 2022. He served as Managing Di...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Rajaram Narayanan	MD, CEO & Director	2.6yrs	₹31.18m	sin datos
Saurav Bhala	Chief Financial Officer	less than a year	₹6.52m	sin datos
Phillip Trott	Secretary	less than a year	₹840.00k	sin datos
Ramesh Pillai	Corporate Vice President of Ra Qa and Technical Services	no data	sin datos	sin datos
Ravi Nair	Executive Vice President of Human Resources & Administration	no data	sin datos	sin datos
Abhishek Singhal	Head of Investor Relations	no data	sin datos	sin datos
Vedprakash Ragate	Executive Director	less than a year	sin datos	sin datos
Prasad Lad	Vice President of HR & Administration	no data	sin datos	sin datos

0.9yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de SEQUENT no se considera experimentado ( 0.9 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Rajaram Narayanan	MD, CEO & Director	2.6yrs	₹31.18m	sin datos
Vedprakash Ragate	Executive Director	less than a year	sin datos	sin datos
Neeraj Bharadwaj	Additional Non-Executive & Non-Independent Director	4.3yrs	sin datos	sin datos
Milind Sarwate	Independent Director	4.3yrs	₹2.10m	sin datos
Kamal Sharma	Independent Chairman	4.3yrs	₹2.00m	sin datos
Fabian Kausche	Additional Non-Executive & Non-Independent Director	3.9yrs	₹500.00k	sin datos
Gregory Andrews	Additional Non-Executive Non-Independent Director	4yrs	₹600.00k	sin datos
Hari Bodepudi	Non Executive Director	1.3yrs	₹400.00k	sin datos

4.0yrs

Permanencia media

64yo

Promedio de edad

Junta con experiencia: La junta directiva de SEQUENT se considera experimentada (4 años de antigüedad promedio).

Sequent Scientific Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Sequent Scientific Limited Announces Cessation of Kausalya Santhanam as Independent Director

Sequent Scientific Limited, Annual General Meeting, Sep 17, 2024

Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024

Sequent Scientific Limited Announces Executive Changes

Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024

Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer

Recent updates

Second quarter 2025 earnings released: EPS: ₹0.11 (vs ₹0.34 loss in 2Q 2024)

Sequent Scientific Limited to Report Q2, 2025 Results on Nov 13, 2024

Sequent Scientific Limited Announces Cessation of Kausalya Santhanam as Independent Director

Sequent Scientific and Viyash Life Sciences Reportedly Explore Merger Worth INR 70,000 Million-INR 80,000 Million

Sequent Scientific Limited (BSE:512529) agreed to acquire Viyash Life Sciences Private Limited for INR 38 billion.

We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt

What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You

Sequent Scientific Limited, Annual General Meeting, Sep 17, 2024

Sequent Scientific Limited Receives WHO Prequalification Approval for Albendazole API

New minor risk - Share price stability

First quarter 2025 earnings released: EPS: ₹0.26 (vs ₹1.40 loss in 1Q 2024)

Sequent Scientific Limited to Report Q1, 2025 Results on Aug 14, 2024

Full year 2024 earnings released: ₹1.44 loss per share (vs ₹4.88 loss in FY 2023)

Sequent Scientific Limited to Report Q4, 2024 Results on May 15, 2024

Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)

Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024

Third quarter 2024 earnings released: EPS: ₹0.33 (vs ₹0.36 loss in 3Q 2023)

Sequent Scientific Limited Announces Executive Changes

Sequent Scientific Limited to Report Q3, 2024 Results on Feb 13, 2024

Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024

Sequent Scientific Limited to Report Q2, 2024 Results on Nov 06, 2023

Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer

Sequent Scientific Limited, Annual General Meeting, Aug 30, 2023

Sequent Scientific Limited to Report Q1, 2024 Results on Aug 10, 2023

Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra

Full year 2023 earnings released: ₹4.88 loss per share (vs ₹1.67 profit in FY 2022)

Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings released: ₹0.36 loss per share (vs ₹0.69 profit in 3Q 2022)

Sequent Scientific Limited Announces Resignation of Rahul Mukim as Director

Price target decreased to ₹149

High number of new and inexperienced directors

Second quarter 2023 earnings released: ₹0.15 loss per share (vs ₹0.58 profit in 2Q 2022)

Sequent Scientific Limited (BSE:512529) agreed to acquire Tineta Pharma Private Limited from group of shareholders for INR 2.18 billion.

Sequent Scientific Limited to Report Q2, 2023 Results on Nov 14, 2022

Sequent Scientific Limited, Annual General Meeting, Sep 20, 2022

First quarter 2023 earnings released: ₹0.57 loss per share (vs ₹0.04 profit in 1Q 2022)

Sequent Scientific Limited to Report Q1, 2023 Results on Aug 08, 2022

Investor sentiment improved over the past week

Sequent Scientific Limited Appoints P V Raghavendra Rao as the Chief Financial Officer

Investor sentiment deteriorated over the past week

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

Sequent Scientific Limited to Report Q4, 2022 Results on May 25, 2022

Price target decreased to ₹170

High number of new and inexperienced directors

Sequent Scientific Limited Announces Resignation of Tushar Mistry Chief Financial Officer, Effective May 31, 2022

Sequent Scientific Limited Announces Resignation of Mr. Manish Gupta from the Position of CEO

Sequent Scientific Limited Announces Appointment of Rajaram Narayanan as Managing Director

CEO, MD & Executive Director recently sold ₹73m worth of stock

Investor sentiment improved over the past week

CEO, MD & Executive Director recently sold ₹84m worth of stock

CEO, MD & Executive Director recently sold ₹23m worth of stock

CEO, MD & Executive Director recently sold ₹27m worth of stock

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to ₹197

Insider recently sold ₹5.7m worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought ₹1.4m worth of stock

Second quarter 2022 earnings released: EPS ₹0.58 (vs ₹0.86 in 2Q 2021)

Investor sentiment deteriorated over the past week

Insider recently sold ₹17m worth of stock

Insider recently sold ₹17m worth of stock

Full year 2021 earnings released: EPS ₹3.87 (vs ₹2.87 in FY 2020)

Insider recently sold ₹1.3m worth of stock

Third quarter 2021 earnings released: EPS ₹1.54 (vs ₹0.83 in 3Q 2020)

New 90-day high: ₹232

Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?

Sequent Scientific Limited to Report Q3, 2021 Results on Feb 03, 2021

New 90-day high: ₹215